financetom
Business
financetom
/
Business
/
nCino Insider Sold Shares Worth $22,207,292, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
nCino Insider Sold Shares Worth $22,207,292, According to a Recent SEC Filing
Jun 21, 2024 12:50 AM

03:32 AM EDT, 06/21/2024 (MT Newswires) -- Jeff Horing, 10% Owner, Director, on June 18, 2024, sold 703,952 shares in nCino (NCNO) for $22,207,292. Following the Form 4 filing with the SEC, Horing has control over a total of 26,686,943 shares of the company, with 111,729 shares held directly and 26,575,214 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1902733/000110465924073592/xslF345X03/tm2417703-1_4seq1.xml

Price: 31.00, Change: -0.30, Percent Change: -0.96

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Thermo Fisher Scientific Says Olink Platform Chosen by UK Proteomics Project
Thermo Fisher Scientific Says Olink Platform Chosen by UK Proteomics Project
Jan 10, 2025
04:21 AM EST, 01/10/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) said late Thursday the UK Biobank Pharma Proteomics Project has chosen its Olink Explore Platform to support a human proteomics study. Financial terms were not disclosed. The project will analyze more than 5,400 proteins from 600,000 samples to help find new biomarkers that could potentially identify, diagnose...
Amylyx Pharmaceuticals Launches Stock Offering
Amylyx Pharmaceuticals Launches Stock Offering
Jan 10, 2025
04:31 AM EST, 01/10/2025 (MT Newswires) -- Amylyx Pharmaceuticals ( AMLX ) said late Thursday it has commenced an underwritten public offering of common shares. Amylyx plans to give the underwriter a 30-day option to buy up to an additional 15% of the shares offered. The company said the proceeds will be used to support commercialization, pipeline programs, working capital...
Zai Lab Licenses MediLink Therapeutics' Antibody-Drug Conjugate Platform
Zai Lab Licenses MediLink Therapeutics' Antibody-Drug Conjugate Platform
Jan 10, 2025
04:39 AM EST, 01/10/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said late Thursday it has struck a licensing agreement to use MediLink Therapeutics' Tmalin antibody-drug conjugate platform for the development of its ZL-6201 investigational drug. Financial terms were not disclosed. Zai Lab ( ZLAB ) said the partnership will expand its oncology pipeline with another drug targeting multiple...
Wynn Resorts to Acquire Crown London Casino
Wynn Resorts to Acquire Crown London Casino
Jan 10, 2025
04:20 AM EST, 01/10/2025 (MT Newswires) -- Wynn Resorts ( WYNN ) disclosed late Thursday a deal to acquire Crown London (Aspinalls), a members-only casino in London's upscale Mayfair district, expanding its European footprint. The company said the planned purchase, whose financial details were not disclosed, will precede the opening of the Wynn Al Marjan Island at Ras Al Khaimah...
Copyright 2023-2026 - www.financetom.com All Rights Reserved